Cryogenic Cold Chain Management

Cryochain control preserves cell quality

Cryopreservation is an important step to maintain cell quality over time or across sites. But traditional techniques are prone to error and can compromise product quality. Through an integrated network of hardware and software, GE Healthcare's end-to-end solution preserves cell viability and function – from freezing to thawing.

Learn why reproducible freezing and thawing is critical for successful cell therapies.

The cryochain begins with freezing

Cells are frozen to preserve them for storage or transportation. Traditional techniques use liquid nitrogen, which provides inconsistent results and risks contaminating the product with particulates. GE Healthcare's
VIA Freeze controlled-rate freezers provide you with a simpler option that overcomes these obstacles.

Visit VIA Freeze shop page

A key stage in delivering sensitive therapies

Cell thawing is often the least controlled part of the cryochain. Thawing in water baths is subjective and carries a risk of microbial contamination. Data from thaw sites are typically collected and collated by paper records, which are not auditable. GE Healthcare's alternative reproducibly maintains your cells’ viability while providing digital traceability.

Visit VIA Thaw shop page

Integrating, managing, and monitoring each stage in the cryochain

Maintaining consistency in freezing and thawing across multiple sites can be a huge challenge. Auditing remote processes is also difficult. The challenges get bigger as cell therapy production scales up. By integrating your cryochain processes with a web-based software platform, you can standardize and audit remote processes from any web browser.

Learn how centralized cryochain control works

Cryochain control preserves cell quality

The cryochain begins with freezing

A key stage in delivering sensitive therapies

Integrating, managing, and monitoring each stage in the cryochain

VIA Freeze system

VIA Thaw system

my.Cryochain software